By Stephanie Brown HealthDay ReporterFRIDAY, May 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...

A new study highlights the Cardio-Ankle Vascular Index (CAVI) as a powerful tool for predicting COPD progression and outcomes ...

Explore the future of the Chronic Obstructive Pulmonary Disease (COPD) market with our comprehensive report. This forecast model covers the 7 major markets from 2023 to 2033, predicting a CAGR of 10%, ...

Approval of Nucala marks the first biologic approved for chronic obstructive pulmonary disease patients with blood eosinophil counts as low as ≥150 cells/μL.

GSK’s Nucala receives US FDA approval for use in adults with chronic obstructive pulmonary disease: London, UK Saturday, May 24, 2025, 11:00 Hrs [IST] GSK plc announced that the ...

Certain groups of physical multimorbidity may be associated with a higher risk of subsequent depression, according to a recent study.

Women with COPD, asthma, and OSA may go undiagnosed or without proper care because their symptomatology differs from the male ...

and lifestyle changes Chronic obstructive pulmonary disease, commonly referred to as COPD, is a group of progressive lung diseases. An estimated 32 million people in the United States have COPD.

AstraZeneca has turned to another digital health partner to support its aspirations in chronic kidney disease (CKD), joining ...

A new study published in the International Journal of Chronic Obstructive Pulmonary Disease showed that regardless of ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...